Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Dale

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 6, 2006
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperativelyHilde Pleym, Vibeke Videm, Alexander Wahba, et al.
The Journal of Pharmacy and Pharmacology|June 30, 2006
Transepithelial transport of morphine and mannitol in Caco-2 cells: the influence of chitosans of different molecular weights and degrees of acetylationOla Dale, Turid Nilsen, Gry Olaussen, et al.
Palliative Medicine|February 18, 2006
Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up studyOlav Magnus S Fredheim, Stein Kaasa, Ola Dale, et al.
Palliative Medicine|December 26, 2003
Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patientsPål Klepstad, Petter C Borchgrevink, Ola Dale, et al.
European Journal of Clinical Pharmacology|March 24, 2018
Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteersArne Kristian Skulberg, Ida Tylleskar, Turid Nilsen, et al.
Substance Abuse|June 28, 2018
Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facilityDesiree Madah-Amiri, Arne Kristian Skulberg, Anne-Cathrine Braarud, et al.
BMC Emergency Medicine|September 6, 2020
Prehospital naloxone administration - what influences choice of dose and route of administration?Ida Tylleskar, Linn Gjersing, Lars Petter Bjørnsen, et al.
European Journal of Clinical Pharmacology|July 8, 2011
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre studyTrine Naalsund Andreassen, Ingrid Eftedal, Pål Klepstad, et al.
BMJ Open|November 13, 2020
NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital useArne Kristian Skulberg, Ida Tylleskär, Anne-Cathrine Braarud, et al.
The Journal of Pharmacy and Pharmacology|October 13, 2006
Intranasal midazolam: a comparison of two delivery devices in human volunteersOla Dale, Turid Nilsen, Thorsteinn Loftsson, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 6, 2006
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperativelyHilde Pleym, Vibeke Videm, Alexander Wahba, et al.
The Journal of Pharmacy and Pharmacology|June 30, 2006
Transepithelial transport of morphine and mannitol in Caco-2 cells: the influence of chitosans of different molecular weights and degrees of acetylationOla Dale, Turid Nilsen, Gry Olaussen, et al.
Palliative Medicine|February 18, 2006
Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up studyOlav Magnus S Fredheim, Stein Kaasa, Ola Dale, et al.
Palliative Medicine|December 26, 2003
Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patientsPål Klepstad, Petter C Borchgrevink, Ola Dale, et al.
European Journal of Clinical Pharmacology|March 24, 2018
Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteersArne Kristian Skulberg, Ida Tylleskar, Turid Nilsen, et al.
Substance Abuse|June 28, 2018
Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facilityDesiree Madah-Amiri, Arne Kristian Skulberg, Anne-Cathrine Braarud, et al.
BMC Emergency Medicine|September 6, 2020
Prehospital naloxone administration - what influences choice of dose and route of administration?Ida Tylleskar, Linn Gjersing, Lars Petter Bjørnsen, et al.
European Journal of Clinical Pharmacology|July 8, 2011
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre studyTrine Naalsund Andreassen, Ingrid Eftedal, Pål Klepstad, et al.
BMJ Open|November 13, 2020
NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital useArne Kristian Skulberg, Ida Tylleskär, Anne-Cathrine Braarud, et al.
The Journal of Pharmacy and Pharmacology|October 13, 2006
Intranasal midazolam: a comparison of two delivery devices in human volunteersOla Dale, Turid Nilsen, Thorsteinn Loftsson, et al.
Pageof 7